Evaluating the Safety and Efficacy of TLD in Patients With COPD
Status:
NOT_YET_RECRUITING
Trial end date:
2029-12-31
Target enrollment:
Participant gender:
Summary
The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard medical care. The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System in the treatment of COPD.
Phase:
PHASE3
Details
Lead Sponsor:
Nuvaira, Inc.
Collaborators:
Honor Health - Clinical Trials Medical College of Wisconsin Ohio State University Royal Brompton & Harefield NHS Foundation Trust Temple Health University of Alabama at Birmingham University of Pittsburgh Medical Center